VERENIUM CORP (DVSA) financial statements (2021 and earlier)
Company profile
| Business Address |
3550 JOHN HOPKINS COURT SAN DIEGO, CA 92121 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 286 - Industrial Organic Chemicals (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2012 | |||
|---|---|---|---|
| ASSETS | |||
| Current Assets | |||
| Cash, cash equivalents, and short-term investments | 35 | ||
| Cash and cash equivalents | 35 | ||
| Restricted cash and investments | 3 | ||
| Receivables | 11 | ||
| Inventory, net of allowances, customer advances and progress billings | 5 | ||
| Inventory | 5 | ||
| Prepaid expense and other current assets | 3 | ||
| Total current assets: | 56 | ||
| Noncurrent Assets | |||
| Property, plant and equipment | 37 | ||
| Prepaid expense and other noncurrent assets | 1 | ||
| Total noncurrent assets: | 37 | ||
| TOTAL ASSETS: | 94 | ||
| LIABILITIES AND EQUITY | |||
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 14 | ||
| Accounts payable | 8 | ||
| Accrued liabilities | 6 | ||
| Taxes payable | 0 | ||
| Debt | (0) | ||
| Deferred revenue and credits | 2 | ||
| Other liabilities | 0 | ||
| Other undisclosed current liabilities | (0) | ||
| Total current liabilities: | 16 | ||
| Noncurrent Liabilities | |||
| Long-term debt and lease obligation, including: | 22 | ||
| Long-term debt, excluding current maturities | 25 | ||
| Other undisclosed long-term debt and lease obligation | (3) | ||
| Liabilities, other than long-term debt | 1 | ||
| Other liabilities | 1 | ||
| Other undisclosed noncurrent liabilities | 25 | ||
| Total noncurrent liabilities: | 48 | ||
| Total liabilities: | 63 | ||
| Stockholders' equity | |||
| Stockholders' equity attributable to parent | 35 | ||
| Common stock | 0 | ||
| Additional paid in capital | 613 | ||
| Accumulated deficit | (582) | ||
| Warrants and rights outstanding | 4 | ||
| Other undisclosed stockholders' equity | (4) | ||
| Total stockholders' equity: | 31 | ||
| TOTAL LIABILITIES AND EQUITY: | 94 | ||
Income statement (P&L) ($ in millions)
| 12/31/2012 | ||
|---|---|---|
| Revenues | 57 | |
| Revenue, net | 52 | |
| Financial services revenue | 31 | |
| Cost of revenue (Cost of Goods and Services Sold) | (32) | |
| Gross profit: | 25 | |
| Operating expenses | (3) | |
| Operating income: | 22 | |
| Nonoperating expense | (3) | |
| Interest and debt expense | (2) | |
| Income from continuing operations before equity method investments, income taxes: | 16 | |
| Other undisclosed income from continuing operations before income taxes | 2 | |
| Income from continuing operations before income taxes: | 18 | |
| Income tax expense | (0) | |
| Other undisclosed loss from continuing operations | (0) | |
| Income from continuing operations: | 18 | |
| Loss from discontinued operations | (0) | |
| Net income: | 18 | |
| Other undisclosed net income attributable to parent | 0 | |
| Net income available to common stockholders, diluted: | 18 | |
Comprehensive Income ($ in millions)
| 12/31/2012 | ||
|---|---|---|
| Net income: | 18 | |
| Comprehensive income: | 18 | |
| Other undisclosed comprehensive income, net of tax, attributable to parent | 0 | |
| Comprehensive income, net of tax, attributable to parent: | 18 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.